Macquarie Group LTD Vertex Pharmaceuticals Inc Transaction History

Macquarie Group LTD

  • $86.4 Billion
  • Q4 2024

A detailed history of Macquarie Group LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Macquarie Group LTD holds 229,933 shares of VRTX stock, worth $116 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
229,933
Previous 326,516 29.58%
Holding current value
$116 Million
Previous $152 Million 39.03%
% of portfolio
0.11%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$396.64 - $516.74 $38.3 Million - $49.9 Million
-96,583 Reduced 29.58%
229,933 $92.6 Million
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $4.25 Million - $4.67 Million
-9,229 Reduced 2.75%
326,516 $152 Million
Q2 2024

Aug 09, 2024
SELL
$392.81 - $485.53 $14.3 Million - $17.7 Million
-36,496 Reduced 9.8%
335,745 $157 Million
Q1 2024

May 14, 2024
SELL
$407.69 - $446.08 $10.2 Million - $11.2 Million
-25,053 Reduced 6.31%
372,241 $156 Million
Q4 2023

Feb 14, 2024
SELL
$343.0 - $410.68 $114 Million - $137 Million
-333,639 Reduced 45.65%
397,294 $162 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $5.58 Million - $5.98 Million
16,498 Added 2.31%
730,933 $254 Million
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $16.3 Million - $18.3 Million
-51,939 Reduced 6.78%
714,435 $251 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $26.3 Million - $30 Million
-92,926 Reduced 10.81%
766,374 $241 Million
Q4 2022

Feb 21, 2023
SELL
$285.76 - $321.48 $10.9 Million - $12.2 Million
-38,008 Reduced 4.24%
859,300 $248 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $9.82 Million - $11 Million
-35,871 Reduced 3.84%
897,308 $260 Million
Q2 2022

Aug 15, 2022
BUY
$234.96 - $292.55 $153 Million - $191 Million
652,321 Added 232.26%
933,179 $263 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $5.18 Million - $6.11 Million
-23,399 Reduced 7.69%
280,858 $73.3 Million
Q4 2021

Feb 11, 2022
SELL
$177.01 - $223.45 $185 Million - $234 Million
-1,046,258 Reduced 77.47%
304,257 $66.8 Million
Q3 2021

Nov 12, 2021
SELL
$181.39 - $202.99 $48.3 Million - $54 Million
-266,259 Reduced 16.47%
1,350,515 $245 Million
Q2 2021

Aug 13, 2021
BUY
$187.49 - $221.1 $275 Million - $324 Million
1,466,287 Added 974.36%
1,616,774 $326 Million
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $2.98 Million - $3.47 Million
14,384 Added 10.57%
150,487 $32.3 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $1.19 Million - $1.58 Million
5,739 Added 4.4%
136,103 $32.2 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $4.97 Million - $5.89 Million
19,437 Added 17.52%
130,364 $35.5 Million
Q2 2020

Aug 11, 2020
BUY
$225.48 - $295.8 $407,442 - $534,510
1,807 Added 1.66%
110,927 $32.2 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $3 Million - $3.72 Million
-15,009 Reduced 12.09%
109,120 $26 Million
Q4 2019

Feb 14, 2020
SELL
$166.71 - $223.91 $2.59 Million - $3.47 Million
-15,512 Reduced 11.11%
124,129 $27.2 Million
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $507,001 - $570,624
3,050 Added 2.23%
139,641 $23.7 Million
Q2 2019

Aug 14, 2019
SELL
$164.61 - $190.37 $3.16 Million - $3.66 Million
-19,219 Reduced 12.33%
136,591 $25 Million
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $579,604 - $689,238
-3,540 Reduced 2.22%
155,810 $28.7 Million
Q4 2018

Feb 15, 2019
BUY
$151.91 - $192.21 $867,861 - $1.1 Million
5,713 Added 3.72%
159,350 $26.4 Million
Q3 2018

Nov 15, 2018
SELL
$167.73 - $192.74 $2.26 Million - $2.6 Million
-13,490 Reduced 8.07%
153,637 $29.6 Million
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $1.98 Million - $2.31 Million
-13,605 Reduced 7.53%
167,127 $28.4 Million
Q1 2018

May 11, 2018
BUY
$151.6 - $177.13 $1.89 Million - $2.21 Million
12,459 Added 7.4%
180,732 $29.5 Million
Q4 2017

Feb 15, 2018
SELL
$137.28 - $155.55 $7.69 Million - $8.71 Million
-56,001 Reduced 24.97%
168,273 $24.9 Million
Q3 2017

Nov 08, 2017
BUY
$148.13 - $162.24 $33.2 Million - $36.4 Million
224,274
224,274 $34.1 Million

Others Institutions Holding VRTX

# of Institutions
1,763
Shares Held
228M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email